Aditxt (NASDAQ:ADTX) Stock Price Up 4.7% – Still a Buy?

Shares of Aditxt, Inc. (NASDAQ:ADTX) traded up 4.7% on Monday . The company traded as high as $1.33 and last traded at $1.22. 910,687 shares changed hands during mid-day trading, a decline of 79% from the average session volume of 4,331,676 shares. The stock had previously closed at $1.1650.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Aditxt in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Aditxt presently has an average rating of “Sell”.

Aditxt Stock Up 4.7%

The business has a fifty day moving average of $10.99 and a 200 day moving average of $84.53. The firm has a market cap of $890,600.00, a P/E ratio of 0.00 and a beta of 1.43.

Aditxt Company Profile

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.